Loading...

Table of Content

    05 August 2012, Volume 16 Issue 32 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    Human umbilical cord mesenchymal stromal cells inhibit the growth of SHG44 cells under direct and indirect co-cultivation
    Liang A-ming, Liang Shuo, Fan Rui-tai, Tian Yi, Chi Lian-kai, Shi Xin-yi, Liu Jin-yu, Guan Fang-xia, Yang Bo
    2012, 16 (32):  5891-5896.  doi: 10.3969/j.issn.2095-4344.2012.32.001
    Abstract ( 235 )   PDF (724KB) ( 318 )   Save

    BACKGROUND: SHG44, a kind of malignant glioma cell line, is easy to cultivate with stable biomedical properties and widely used in the animal models of tumors. The current studies focus on inhibiting SHG44 growth by drugs, gene transfection and ionizing radiation. There have been no reports describing the effects of mesenchymal stem cells on biological characteristics of SHG44.
    OBJECTIVE: To investigate the cell cycle and the number of SHG44 cells which were directly and indirectly co-cultured with human umbilical cord mesenchymal stem cells.
    METHODS: Human umbilical cord mesenchymal stem cells and SHG44 cells were directly co-cultured in the 24-well plate and indirectly co-cultured in the Transwell plate. A control group was designed for the direct and indirect co-culture separately. After co-culture for 3 d, cells were observed under fluorescence microscope, and SHG44 cells were collected for detection of SHG44 cell cycle by flow cytometry.
    RESULTS AND CONCLUSION: Compared with corresponding controls, the number of SHG44 cells fluorescently labeled decreased after directly co-cultured with MSCs (P < 0.05); the number of SHG44 cells fluorescently labeled had no change after indirectly co-cultured with MSCs (P > 0.05). The proportion of SHG44 cells at G0/G1 stage was significantly higher than that in the control group (P < 0.05). The results confirmed that human umbilical cord mesenchymal stem cells cultured in vitro can inhibit the proliferation of SHG44 cells by direct and indirect ways in vitro.

    Related Articles | Metrics
    Expression of embryonic stem cell-related transcription factors in human umbilical cord mesenchymal stem cells
    Han Zhi-bo, Chi Ying, Yang Shao-guang, Wang You-wei, Yang Zhou-xin, Ji Yue-ru, Yang Ping, Han Zhong-chao
    2012, 16 (32):  5897-5896.  doi: 10.3969/j.issn.2095-4344.2012.32.002
    Abstract ( 293 )   PDF (770KB) ( 401 )   Save

    BACKGROUND: By regulating gene transcription in embryonic stem cells, Nanog, Oct4 and Sox2 play a key role in the regulation of pluripotency and self-renewal. Expression of embryonic stem cell-associated transcription factors in umbilical cord mesenchymal stem cells has not been fully clarified.
    OBJECTIVE: To investigate the expression of embryonic stem cell-associated transcription factor-Nanog, Oct4 and Sox2 in umbilical cord mesenchymal stem cells.
    METHODS: Umbilical cord mesenchymal stem cells were cultured with collagenase and trypsinase digestion. Human embryonic stem cells were cultured in the mTeSRTM1 system in the absence of trophoderm. The difference in Nanog, Oct4 and Sox2 mRNA expression was compared between umbilical cord mesenchymal stem cells and embryonic stem cells by quantitative PCR. Nanog, Oct4 and Sox2 expression in umbilical cord mesenchymal stem cells and embryonic stem cells was determined by immunofluorescent staining.
    RESULTS AND CONCLUSION: Nanog, Oct4 and Sox2 were expressed in human umbilical cord mesenchymal stem cells. However, Oct4, in particular Oct4B, was mainly located in the cytoplasm of human umbilical cord mesenchymal stem cells. Nanog, Oct4 and Sox2 expression was significantly lower in the umbilical cord mesenchymal stem cells than in the embryonic stem cells, and the mRNA expression of Nanog, Oct4 and Sox2 in the umbilical cord mesenchymal stem cells was 20%, 0.3% and 10% of that in the embryonic stem cells. This study revealed the different expression profiles of Nanog, Oct4 and Sox2 in umbilical cord mesenchymal stem cells and embryonic stem cells. It is beneficial to optimizing the methods of reprogramming umbilical cord mesenchymal stem cells and analyzing the function of embryonic stem cell-associated transcription factors in adult stem cells.

    Related Articles | Metrics
    Stromal cell-derived factor-1 preconditioning inhibits apoptosis of rat bone marrow mesenchymal stem cells
    Shu Bo, Liu Zhi-jiang, Fan Fang
    2012, 16 (32):  5903-5908.  doi: 10.3969/j.issn.2095-4344.2012.32.003
    Abstract ( 226 )   PDF (518KB) ( 342 )   Save

    BACKGROUND: Studies demonstrated that stromal cell-derived factor-1 may participate in anti-apoptosis of mesenchymal stem cells in addition to directed migration.
    OBJECTIVE: To investigate that stromal cell-derived factor-1 preconditioning inhibits apoptosis of MSCs.
    METHODS: Apoptosis of rat bone marrow mesenchymal stem cells was induced with different concentrations of H2O2. H2O2 at the optimal concentration of 100 μmol/L was used for experiments. Rat bone marrow mesenchymal stem cells were induced with 100 μmol/L H2O2 and then treated with stromal cell-derived factor-1 at different concentrations, and stromal cell-derived factor-1 at the optimal concentration was used for experiment. Passage 3 rat bone marrow mesenchymal stem cells were randomly divided into four groups. The normal control group was treated with nothing. The injured group was treated with 100 μM H2O2 for 24 hours. The stromal cell-derived factor-1 preconditioning group was treated with stromal cell-derived factor-1 at 6 hours before H2O2 addition. The stromal cell-derived factor-1+AMD3100 (an antagonist of stromal cell-derived factor-1 receptor CXCR4) group was incubated with stromal cell-derived factor-1 and AMD3100 at 6 hours before H2O2 addition.
    RESULTS AND CONCLUSION: H2O2 could mimic ischemic environment and induce the apoptosis of bone marrow mesenchymal stem cells in a dose-dependent manner in vitro. After stromal cell-derived factor-1 preconditioning, cell apoptosis was significantly alleviated (P < 0.01), E2F6 and E2F1 mRNA expression was significantly increased (P < 0.05), cytochrome c translocation was significantly reduced (P < 0.05), caspase-3 activity was decreased (P < 0.05) compared with the injured group. AMD3100 could block the protective effect of stromal cell-derived factor-1 on bone marrow mesenchymal stem cells. These results suggest that stromal cell-derived factor-1 is capable to reduce the apoptosis of bone marrow mesenchymal stem cells by upregulating E2F6 mRNA expression, negatively regulating E2F1 mRNA expression, and decreasing cytochrome c release.

    Related Articles | Metrics
    In vivo and in vitro tracking of bone marrow mesenchymal stem cells delivered to infarcted myocardium by superparamagnetic iron oxide nanoparticles
    Adila·Azat, Ma Xiang, Chen Bang-dang, Liu Fen, Ma Yi-tong
    2012, 16 (32):  5909-5914.  doi: 10.3969/j.issn.2095-4344.2012.32.004
    Abstract ( 245 )   PDF (621KB) ( 324 )   Save

    BACKGROUND: In vivo tracking of transplanted stem cells and evaluating the dynamic changes of transplanted stem cells by imageological means is currently a rapidly growing area of research.
    OBJECTIVE: To investigate the feasibility of in vivo and in vitro tracking of mesenchymal stem cells delivered to infarcted myocardium by surpurparamagnetic iron oxide nanoparticles.
    METHODS: Eight pig models of acute myocardial infarction were successfully established by occlusion of anterior descending coronary artery with balloon and were then randomly divided into two groups. In the experimental group, at 2 weeks after acute myocardial infarction induction, 1 mL bone marrow mesenchymal stem cells labeled by the mixture of surpurparamagnetic iron oxide nanoparticles and polylysine were injected via five points in the center and border of infracted region. Equal amounts of physiological saline were identically injected in the control group.
    RESULTS AND CONCLUSION: At 1 hour, 2 weeks after cell transplantation, MRI images of experiment group showed obvious low signal of transplantation region in all four pigs. At 4 weeks after transplantation, desmin, connexin and transcription protein were detected by fluorescent immunohistochemical staining. In vivo tracking of surpurparamagnetic iron oxide nanoparticles-labeled bone marrow mesenchymal stem cells by MRI is feasible and effective.

    References | Related Articles | Metrics
    Prolyl hydroxylase inhibitor prevents bone marrow mesenchymal stem cells apoptosis in mice
    Zhang Lei, Zhao Xue-ling, Li Biao, Liu Jin-song, Li Xi, Gong Yue-kun
    2012, 16 (32):  5915-5919.  doi: 10.3969/j.issn.2095-4344.2012.32.005
    Abstract ( 304 )   PDF (370KB) ( 410 )   Save

    BACKGROUND: Prolyl hydroxylase inhibitors can stabilize hypoxia inducible factor to up-regulate downstream genes expression, thereby regulating cell apoptosis.
    OBJECTIVE: To evaluate the effects of the prolyl hydroxylase inhibitors dimethyloxalglycine (DMOG) on apoptosis of bone marrow-derived mesenchymal stem cells (BMSCs) induced by serum deprivation.
    METHODS: Bone marrow mononuclear cells were harvested from Kunming mice bone marrow cavity of the femur and tibia and subcultured. The passage five mononuclear cells were identified by flow cytometry and tri-lineage differentiation. Bone marrow mononuclear cells were cultured in serum-free DMEM for serum deprivation (serum-deprivation group) and DMEM containing 10% fetal bovine serum (normal control group) for 24, 48, and 72 hours. Experimental group was treated with 1 mmol/L DMOG based on serum-free culture.
    RESULTS AND CONCLUSION: The bone marrow mononuclear cells from the mice were purified through subculture and were verified as BMSCs through cell surface marker identification by flow cytometry. Compared with serum-deprivation group, the apoptosis rate was significantly decreased in experimental group (P < 0.01). Results indicate that DMOG can suppress BMSCs apoptosis induced by serum deprivation.

    Related Articles | Metrics
    Bone marrow-derived mesenchymal stem cells differentiation into cardiomyocyte-like cells in myocardial microenvironment
    Hu Bo, Gao Pan, Ma Zhi-feng, Zhang Zhi-feng, Zhang Zhong-ming, Yuan Hong-hua, Dong Hong-yan
    2012, 16 (32):  5920-5925.  doi: 10.3969/j.issn.2095-4344.2012.32.006
    Abstract ( 302 )   PDF (434KB) ( 391 )   Save

    BACKGROUND: It remains unclear whether bone morphogenetic protein (BMP), Wnt, Notch, FGF and Hedgehog signaling pathways are involved in differentiation of cardiomyocytes from bone marrow-derived mesenchymal stem cells (BMSCs).
    OBJECTIVE: To investigate the ability of BMSCs differentiating into cardiomyocytes-like cells and their differentiating mechanism of signal pathways in myocardial microenvironment.
    METHODS: Myocardial microenvironment was established by the technology of Transwell, and Wnt11 and BMP2 were used to induce BMSCs differentiation into cardiomyocyte-like cells. RT-PCR and western blot were used to detect expression of key signaling molecules of BMP, Wnt, Notch, FGF and Hedgehog signaling pathways. In addition, expression of cardiac-specific transcription factors, Nkx2.5, GATA4, and Mef2c, and mature cardiac-specific genes, cTnI, ANP, α-MHC, and β-MHC, was detected.
    RESULTS AND CONCLUSION: After co-culture with rat cardiomyocytes, in the BMSCs, the expression of key signaling molecules of Wnt, BMP, Notch, Hedgehog signal pathways was significantly higher than the non-induced negative control group (P < 0.01). After adding BMP signal pathway inhibitor, Noggin, cardiac-specific transcription factors or structural proteins Nkx-2.5, GATA4, α-MHC, β-MHC, cTnI expression was significantly reduced (P < 0.01). Results indicate that myocardial microenvironment can induce rat BMSCs to differentiate into cardiomyocyte-like cells. Wnt, BMP, Notch, FGF and Hedgehog signaling pathways were all involved in the process.

    Related Articles | Metrics
    Induced differentiation of bone marrow mesenchymal stem cells into adipocytes in vitro
    Zheng Liang, Li Ping-hua, Liu Yu-yu, Cui Liao
    2012, 16 (32):  5926-5930.  doi: 10.3969/j.issn.2095-4344.2012.32.007
    Abstract ( 240 )   PDF (440KB) ( 585 )   Save

    BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) are able to differentiate into different cell lineages such as adipocytes and osteoblastes. Establishing a stable and reliable induction method to induce BMSCs to differentiate into adipocytes is of great help in studying prevention and treatment of osteoporosis and skeletal-related diseases.
    OBJECTIVE: To investigate the optimal conditions for induced differentiation of BMSCs into adipocytes.
    METHODS: Under aseptic condition, rat femur was harvested. BMSCs were isolated and purified by density-gradient centrifugation and adherent culture in vitro. After complete confluency, passage 3 BMSCs were induced to differentiate into adipocytes using DMEM containing 3-isobutyl-1-methylxanthine, indomethacin, dexamethasone, insulin and fetal bovine serum.
    RESULTS AND CONCLUSION: Under the inverted microscope, highly homogenous BMSCs could be harvested after three passages, and these cells could be induced to differentiate into adipocytes. BMSCs could be committedly to differentiate into adipocytes in vitro after induced by 3-isobutyl-1-methylxanthine, indomethacin, dexamethasone. 5×10-4 mol/L 3-isobutyl-1-methylxanthine, 2×10-4 mol/L indomethacin and 10-4 mol/L dexamethasone exhibited better effects on induced differentiation of BMSCs into adipocytes. The best condition for inducing BMSCs to differentiate into adipocytes in vitro was DMEM supplemented with 0.1 mmoL/L 3-isobutyl-1-methylxanthine, 10 mg/L insulin, 0.1 mmoL/L indomethacin, 1 μmoL/L dexamethasone, and 10% fetal bovine serum.

    Related Articles | Metrics
    Effects of recombinant human erythropoietin on migration and adhesion of human mesenchymal stem cells
    Lin Hai-hong, Luo Xin-ping, Shi Hai-ming, Gong Hui
    2012, 16 (32):  5931-5935.  doi: 10.3969/j.issn.2095-4344.2012.32.008
    Abstract ( 257 )   PDF (398KB) ( 331 )   Save

    BACKGROUND: Previous studies have demonstrated that erythropoietin can promote the proliferation, differentiation and adhesion of endothelial progenitor cells.
    OBJECTIVE: To investigate the effects and related cell signaling pathways of recombinant human erythropoietin on migration and adhesion of human mesenchymal stem cells.
    METHODS: After being cultured in vitro, passage 6 human mesenchymal stem cells were treated with recombinant human erythropoietin. Recombinant human erythropoietin, phosphorylation of ERK 1/2, p38MAPK and PI3K/Akt were detected by western blot. After 24 hours of pretreatment with 1U/mL recombinant human erythropoietin, cell migration assay was performed in Transwell chambers, and adhesion assay was performed by plastic dishes.
    RESULTS AND CONCLUSION: Recombinant human erythropoietin could increase phosphorylation of PI3K/Akt pathway of human MSCs, but reduce phosphorylation of p38MAPK. It had no obvious effect on ERK1/2 pathway and total proteins of Akt and p38MAPK. The number of cells crossing the filter was significantly increased in the recombinant human erythropoietin group (P < 0.01). This effect was completely inhibited by concomitant incubation with Ly294002. After treated with recombinant human erythropoietin, adherent cells increased significantly (P < 0.01). Neither Ly294002 nor anisomycin could inhibit this effect. Recombinant human erythropoietin could increase migratory and adhesive capacities of human mesenchymal stem cells. Activation of PI3K/Akt pathway was involved in the effect of recombinant human erythropoietin on cell migration. The effect of rhEPO on adhesion capacity had nothing to do with PI3K/Akt and p38MAPK pathway.

    Related Articles | Metrics
    Proliferation and differentiation potential of bone marrow-derived mesenchymal stem cells in adult patients with aplastic anemia versus in healthy adults
    Cheng Mei, Zhang Hao, Tao Yan-ling, Cheng Huan-chen, Wang Zhi-guo, Chen Bo, Xiao Liang, Xia Guo-qiang, Qiu Lin, Zhan Zhao-min, Zhang Bo-long, Ma Jun
    2012, 16 (32):  5936-5940.  doi: 10.3969/j.issn.2095-4344.2012.32.009
    Abstract ( 472 )   PDF (459KB) ( 468 )   Save

    BACKGROUND: Bone marrow-derived mesenchymal stem cells (BMSCs) have adipogenic and osteogenic differentiation potential. BMSCs in patients with aplastic anemia (AA) may suffer from adipogenic and osteogenic differentiation abnormality.
    OBJECTIVE: To compare the proliferation and differentiation potential of BMSCs in AA patients versus in healthy adults.
    METHODS: AA group included five adult patients who received treatment in the Institute of Hematology & Oncology, Harbin First Hospital. Control group consisted of five healthy adults. BMSCs were isolated by whole bone marrow culture method.
    RESULTS AND CONCLUSION: BMSCs were isolated and purified successfully and effectively. Morphology and immunophenotype of BMSCs from AA group showed no significant difference compared with control group. Two groups were all positive for MSC-related antigens, such as CD73, CD90, CD105, but negative for CD34, CD45, and HLA-DR. Compared with the control group, BMSC proliferation was significantly lower (P < 0.05), the frequency of adipocyte differentiation was significantly higher (P < 0.05), PPARγ mRNA and FABP4 mRNA expression was significantly higher (P < 0.05), the frequency of osteoblast differentiation was significantly lower (P < 0.05), and ALP mRNA and BGLAP mRNA expression was significantly decreased (P < 0.05) in the AA group. These findings suggest that BMSCs from AA patients exhibit unbalanced differentiation potential of osteogenesis and adipocyte.

    References | Related Articles | Metrics
    Biological characteristics of adipose stem cells from buccal fat pad and traditional liposuction
    Zhang Sheng-min, Chen Gang, Wang Chen-xing, Gao Zhen-jie, Qiao Feng
    2012, 16 (32):  5941-5945.  doi: 10.3969/j.issn.2095-4344.2012.32.010
    Abstract ( 260 )   PDF (412KB) ( 340 )   Save

    BACKGROUND: Most of human adipose-derived stem cells studies describe the biological characteristics of subcutaneous fat and visceral fat. There are few studies focusing on buccal fat pad.
    OBJECTIVE: To extract human buccal fat pad adipose-derived stem cells for in vitro proliferation and osteogenic induction and compare the biological characteristics of adipose stem cells from buccal fat pad and traditional liposuction.
    METHODS: Adipose-derived stem cells were harvested from buccal fat pad and traditional liposuction. Then cells were in vitro cultured and induced for osteogenic differentiation. Cell density, proliferation activity and osteogenic capacity were compared between these two kinds of cells.
    RESULTS AND CONCLUSIONS: Human buccal fat pad exhibited more blood vessels than subcutaneous fat. Higher densities of adipose-derived stem cells were obtained from buccal fat pad than traditional liposuction. CCK-8 test showed that the proliferation activity of adipose-derived stem cells from buccal fat pad was significantly higher than that from traditional liposuction (P < 0.05). After osteogenic culture for 3, 7, 14 days, alkaline phosphatase activity was significantly greater in the adipose-derived stem cells from buccal fat pad than that from the traditional liposuction (P < 0.05). These findings suggest that the biological characteristics of adipose-derived stem cells from the buccal fat pad, a special deep fat tissue, are superior to those of adipose-derived stem cells from the traditional liposuction. Moreover, because of its close anatomical relationship to oral maxillofacial region, buccal fat pad can be used as a potential ideal seed cell source for bone tissue engineering in the oromaxillo facial region.

    Related Articles | Metrics
    Isolation, culture and biological characteristics of human adipose-derived stem cells in vitro
    Tian Lin, Sun Xiao-Fang, Liu Hai-Bo, Luo Yu-Mei, Chen Xin-Jie,Huang Dong-Jian
    2012, 16 (32):  5946-5952.  doi: 10.3969/j.issn.2095-4344.2012.32.011
    Abstract ( 671 )   PDF (647KB) ( 1188 )   Save

    BACKGROUND: Human adipose-derived stem cells are widely used as seed cells in tissue engineering and regenerative medicine. Therefore, harvesting a large number of high-purity human adipose-derived stem cells is important for above-mentioned studies.
    OBJECTIVE: To explore the suitable culture condition of human adipose-derived stem cells in vitro, and to enhance the proliferative ability of human adipose-derived stem cells.
    METHODS: Collagenase I was used to digest and isolate human adipose-derived stem cells from intact fat of human abdomen. Human adipose-derived stem cells were purified using attachment method, cultured with low-glucose medium and passaged in vitro. Morphology was observed after Giemsa staining; the growth curve was drawn and cell cycle was analyzed. The karyotype of the passaged human adipose-derived stem cells was analyzed. Cells at the third passage were subjected to flow cytometry analysis, EdU incorporation and colony forming experiments.
    RESULTS AND CONCLUSION: The morphology of primary cultured human adipose-derived stem cells was not the same, passaged human adipose-derived stem cells were spindle-shaped and arranged tightly in a vortex-like appearance. The growth curve was “S” shaped. Cell cycle analysis and EdU incorporation results showed that human adipose-derived stem cells cultured in vitro could maintain strong proliferative ability. Karyotype mapping showed that in vitro culture could not cause chromosome abnormalities of adipose-derived stem cells. Flow cytometry analysis showed that passage 3 adipose-derived stem cells were positive for CD29, CD44, CD90 and CD105, but they were negative for CD34 and CD45, with a clone formation rate of 8.8%. Under certain induction condition, adipose-derived stem cells could differentiate into adipocytes and osteoblasts. Human adipose-derived stem cells were successfully isolated by collagenase digestion method, cultured in vitro and showed strong proliferative ability.

    Related Articles | Metrics
    Osteogenic and chondrogenic differentiation potential of human adipose-derived mesenchymal stem cells
    Zhu Yin, Xu Wei-yuan, Wang Wen-jia, Zhang Xing-xiang, Yan Fei, Sha Wei-ping, Zhu Xian-wei
    2012, 16 (32):  5953-5958.  doi: 10.3969/j.issn.2095-4344.2012.32.012
    Abstract ( 261 )   PDF (574KB) ( 397 )   Save

    BACKGROUND: Human adipose-derived mesenchymal stem cells are a kind of adult stem cells with the high ability of proliferation and multi-lineage differentiation. They can be acquired from the cosmetic liposuction operation with rich sources of raw material and the selections are very convenient. They have a potential value in the field of bioremediation.
    OBJECTIVE: To establish a method of isolating and culturing human adipose-derived mesenchymal stem cells and investigate the proficiency of basic biological characteristics and the potential ability of osteogenic and chondrogenic differentiation.
    METHODS: The adipose tissue was taken from the liposuction operation, human adipose-derived mesenchymal stem cells were isolated by type II collagen enzyme digestion and then cultured in vitro. Cell morphology was observed, cell cycle was determined, and cell surface markers were identified with flow cytometry. Passage 3 cells were assigned to two induction groups A, B and two control groups A, B. Then the cells were induced to differentiate into osteoblasts and chondrocytes with different culture media in vitro. The differentiated cells were identified by histochemical staining, immunocytochemical staining and RT-PCR.
    RESULTS AND CONCLUSION: After in vitro culture, human adipose-derived mesenchymal stem cells showed the desmoids shape. The primary cells adhered to the wall in 24 hours, and then formed the colony after 5-7 days. The passaged cells adhered to the wall in 4-6 hours and maintained the same shape. Cell cycle studies showed that cells at G0/G1, S and G2/M accounted for (88±2)% (88±2)% and 0.03% respectively. The flow cytometry examination showed that the cells were positive for CD29 and CD105 but they were negative for CD45. RT-PCR showed that after osteogenic induction, human adipose-derived mesenchymal stem cells had positive osteopontin mRNA expression; after chondrogenic induction, cells had positive type II collagen mRNA expression. Human adipose-derived mesenchymal stem cells were successfully isolated and cultured and the cells exhibit the potential to differentiate into osteoblasts and chondrocytes.

    Related Articles | Metrics
    Effects of eucommia water/alcohol extract on proliferation and osteogenic differentiation of rabbit adipose derived mesenchymal stem cells
    Guo Yan-wei, Li Song, Fang Dian-ji
    2012, 16 (32):  5959-5962.  doi: 10.3969/j.issn.2095-4344.2012.32.013
    Abstract ( 288 )   PDF (448KB) ( 435 )   Save

    BACKGROUND: Conventional Chinese medicine eucommia can promote the osteogenic differentiation of adipose derived mesenchymal stem cells.
    OBJECTIVE: To investigate the effects of eucommia water/alcohol extract on the proliferation and osteogenic differentiation of adipose derived mesenchymal stem cells.
    METHODS: The rabbit adipose tissue was taken for in vitro culture of adipose derived mesenchymal stem cells. Passage 3 cells were used for study of cell proliferation ability and osteogenic differentiation. The experimental group cells were treated with induced medium containing 0.2, 0.3, 0.4, 0.5 g/L eucommia water/alcohol extract. The control group cells were treated with equal amounts of phosphate buffered saline. After osteogenic induction for 6 days, cell proliferation ability and alkaline phosphatase activity were determined. After osteogenic inducation for 14 days, alizarin red staining was performed and calcified nodules were counted.
    RESULTS AND CONCLUSION: Eucommia water/alcohol extract did not produce effects on the proliferation of adipose derived mesenchymal stem cells, but it significantly up-regulated the activity of alkaline phsphatase. Eucommia alcohol extract exhibited stronger regulatory effects than eucommia water extract at the same dilutions, and eucommia water/alcohol extract at 0.4-0.5 g/L dilutions significantly promoted the formation of calcified nodules (P < 0.05). These findings suggest that eucommia water/alcohol extract promotes the osteogenic differentiation of adipose derived mesenchymal stem cells, and eucommia alcohol extract exhibits better effects than eucommia water extract.

    Related Articles | Metrics
    Induction of pluripotent stem cells from mouse embryonic fibroblast cultures by three defined factors
    Liu Hai-ming, Zhang Zhen, Yang Li, Yang Rui, Sun Jia, Wu Li-feng, Chen Hong, Cai De-hong, Zhang Hua
    2012, 16 (32):  5963-5966.  doi: 10.3969/j.issn.2095-4344.2012.32.014
    Abstract ( 384 )   PDF (387KB) ( 514 )   Save

    BACKGROUND: The study of embryonic stem cells is always confined to ethical disputation or lack of ootid. Scholars are trying to seek a method to obtain multi-potential stem cells which would not destroy the embryo or egg cells.
    OBJECTIVE: To construct and identify the induced pluripotent stem cells from mouse embryonic fibroblasts by three defined factors.
    METHODS: Three stem cell genes (Oct4, Sox2 and Klf4) were introduced into the embryonic fibroblasts of BALB/C mouse by retroviral infection. The induced pluripotent stem cells constructed by this method were analyzed in many aspects, including surface antigens, gene expression, alkaline phosphatase activity and teratoma formation assays.
    RESULTS AND CONCLUSION: The induced pluripotent stem cells generated from this study had an embryonic stem cell-like shape, were positive for alkaline phosphatase staining, expressed embryonic stem cell-specific surface antigens, and possessed the ability to differentiate into 3-germ layers both in vivo and in vitro. So the induced pluripotent stem cells can be obtained from mouse embryonic fibroblasts by introducing three factors, which are similar to embryonic stem cells in many ways.

    Related Articles | Metrics
    Time-dependent morphological characteristics of mouse embryonic stem cells differentiating into osteoblasts
    Shi Xiao-lu, Li Hua-jing, Ma Yan, Bi Xiao-juan, Xie Feng-lian, Wang Lu-xiang,Liu Li-zhong
    2012, 16 (32):  5967-5972.  doi: 10.3969/j.issn.2095-4344.2012.32.015
    Abstract ( 204 )   PDF (696KB) ( 293 )   Save

    BACKGROUND: Nano-hydroxyapatite has good biocompatibility and bioactivity. It can tightly connect with in vitro tissues within a short time. Therefore, nano-hydroxyapatite has been widely used for bone tissue engineering.
    OBJECTIVE: To investigate the time-dependent morphological characteristics of mouse embryonic stem cells differentiating into osteoblasts.
    METHODS: P3 embryonic stem cells from C57 mouse were prepared into embryoid bodies. Primary embryonic stem cells were identified by alkaline phosphatase staining and immunohistochemical analysis (oct 4, sox2, nanog). After osteogenic induction by L-vitamin C, β-phosphoglycerol, and dexamethasone, cells were identified by alizarin red S, collagen Ⅰ, and von Kossa staining. The morphology and proliferation of cells when cultured with nano-hydroxyapatite were observed using scanning electron microscope.
    RESULTS AND CONCLUSION: The expression of alkaline phosphatase showed no obvious change in each group within 7 days after adherence of embryoid bodies, but increased gradually after 14 days. Green nodules of varying size with clear border could be seen under optical microscope. After Alizarin red S staining, orange red nodules of varying size with clear border could be observed. Black precipitates appeared in the cell mass after von Kossa staining for 14 days, and amplified after 21 days. After co-culture with nano-hydroxyapatite for 1, 3, 5, 7, 10 days, the majority of embryonic stem cells grew in cell mass. These findings suggest that co-application of vitamin C, β-phosphoglycerol and dexamethasone effectively promote embryonic stem cells to differentiate into osteoblasts; embryonic stem cells composited onto scaffold material can be used in bone tissue engineering.

    Related Articles | Metrics
    Cell surface markers during chondrogenic indution of mesenchymal stem cells derived from mouse hair follicle in vitro
    Bin Zhi-wen, Chen Li-xia
    2012, 16 (32):  5973-5977.  doi: 10.3969/j.issn.2095-4344.2012.32.016
    Abstract ( 278 )   PDF (445KB) ( 408 )   Save

    BACKGROUND: Mesenchymal stem cells derived from mouse hair follicle possess multipotential differentiation ability. There have been few reports describing cell surface marker during chondrogenic induction process of mesenchymal stem cells derived from mouse hair follicle in vitro.
    OBJECTIVE: To investigate cell morphology, cell surface markers and sulfate glycosaminoglycan level during chondrogenic induction of mesenchymal stem cells derived mouse hair follicle.
    METHODS: IRC newborn mouse skin stem cells were in vitro isolated and cultured. Then cells were cultured with chondrogenic culture medium for 7 and 14 days for determination of indices.
    RESULTS AND CONCLUSION: After treated with chondrogenic medium, the counts of CD44+ cells did not increase dramatically and the level of sulfate glycosaminoglycan was not changed, but the counts of CD54+ cells and CD166+ cells were significantly increased and the levels of corresponding sulfate glycosaminoglycans showed the same increasing tendency. These results suggest that mesenchymal stem cells derived from mouse hair follicle could differentiate into chondrocyte-like cells under the induction of medium; CD44 could not be used as the cell surface marker of chondrogenic differentiation of mesenchymal stem cells derived from mouse hair follicle, while CD54 and CD166 as well as corresponding sulfate glycosaminoglycans are competent for cell surface from marker of chondrogenic differentiation of mesenchymal stem cells derived from mouse hair follicle.

    Related Articles | Metrics
    Hair follicle stem cells in repair of sciatic nerve injury
    Ke Jin-cheng, Cheng Bo
    2012, 16 (32):  5978-5982.  doi: 10.3969/j.issn.2095-4344.2012.32.017
    Abstract ( 287 )   PDF (570KB) ( 427 )   Save

    BACKGROUND: Hair follicle stem cells are multipotent which can differentiate into neurons and repair injured peripheral nerves.
    OBJECTIVE: To investigate the effects of hair follicle stem cells on repair of injured sciatic nerve.
    METHODS: Hair follicle stem cells were isolated and cultured in vitro. Thirty-six healthy rats were selected to prepare sciatic nerve crush injury models with clamping method. Subsequently, rats were randomly divided into a transplantation group and a control group, with eighteen rats in each group. Rats in the transplantation group underwent transplantation of 50 μL of hair follicle stem cells at a concentration of 106/L into nerve injured sites. At the same time, equal amount of PBS was injected into the rats in the control group.
    RESULTS AND CONCLUSION: Nestin, CK19, anti-integrin beta 1 positive cells could be found at injured nerve in the transplantation group 4 and 8 weeks after surgery. Sciatic nerve function indices in the transplantation group superiorly recovered to those in the control group 3-6 weeks after surgery. Hair follicle stem cells transplanted into injured nerve tissue promote the recovery of injured sciatic nerve.

    Related Articles | Metrics
    Separation and identification of cancer stem cells in synovial sarcoma SW982 cell lines
    Huang Zhe, Xilinbaoleri
    2012, 16 (32):  5983-5987.  doi: 10.3969/j.issn.2095-4344.2012.32.018
    Abstract ( 325 )   PDF (489KB) ( 485 )   Save

    BACKGROUND: Synovial sarcomas are highly malignant tumor, but there is no effective treatment method. The tumor stem cell theory provides a new approach for the treatment of synovial sarcomas.
    OBJECTIVE: To explore whether stem-like cells exist in synovial sarcoma SW982 cell lines.
    METHODS: We cultured SW982 cells in a low concentration of serum medium, and the cells which were cultured in the lowest concentration of serum medium were selected for the drug-resistant experiment. The inhibition rate of tumor cells cultured under different concentrations of adriamycin (1, 10, 20, 30, 40, 50, 60 mg/L) were tested by MTT assay. We performed tumorigenicity experiments in the nude mice with the drug-resistant and non-drug-resistant cells respectively.
    RESULTS AND CONCLUSION: Drug-resistant capacity of SW982 cells was improved after cultured with low concentration of serum. In the tumorigenicity experiments, there were two nude mice in which a tumor formed after injected with drug-resistant cells; and tumors did not form in the others. There are high tumorigenicity tumor stem-like cells in the SW982 cell lines. We can collect high tumorigenicity synovial sarcoma cell line effectively with high concentration of adriamycin, and enrich the synovial sarcoma stem cells, but the cells need further purification.

    Related Articles | Metrics
    Effect of Wnt/β-Catenin signal pathway adjusted by suppressor of cytokine signaling 3 on tumor stem cells and its application in treatment of glioblastoma multiforme
    Wu Wei
    2012, 16 (32):  5988-5992.  doi: 10.3969/j.issn.2095-4344.2012.32.019
    Abstract ( 547 )   PDF (449KB) ( 582 )   Save

    BACKGROUND: Several studies have demonstrated that suppressor of cytokine signaling 3 (SOCS3) and Wnt/β-Catenin signal pathway are associated with the occurrence of glioblastoma multiforme.
    OBJECTIVE: To investigate the effect of Wnt/β-Catenin adjusted by SOCS3 on tumor stem cells and its application in treatment of glioblastoma multiforme.
    METHODS: GBM stem cells were isolated from resected glioblastoma multiforme tissues. Then they were also cultured and identified. SOCS3 was amplified by RT-PCR and transfected to glioblastoma multiforme stem cells. RT-PCR and western blotting were employed to determine the mRNA and protein expression of SOCS3, signal transducer and activator of transcription 3 (STAT3), β-Catenin and phosphatase and tensin homology deleted on chromosome ten (PTEN) before and after transfection.
    RESULTS AND CONCLUSION: After SOCS3 transfection, the expression of SOCS3 increased, thus the expression of STAT3 and β-Catenin decreased significantly (P < 0.05). However, Wnt/β-Catenin signal pathway was inhibited. The activity of PTEN was increased significantly (P < 0.05). High expression of SOCS3 can inhibit the conduction of Wnt/β-Catenin signal pathway by decreasing the expression of STAT3. It can also enhance the activity of PTEN, and decrease the proliferation and invasion ability of glioma cells significantly while inducing apoptosis. It offers a new way for target therapy of glioblastoma multiforme.

    Related Articles | Metrics
    Primary culture of human periodontal ligament stem cells and dental pulp stem cells by tissue enzymatic digestion method
    Li Ying, Gu Zi-ya, Lü Qiu-feng, You Jin-biao, Liu Fang-fei
    2012, 16 (32):  5993-5998.  doi: 10.3969/j.issn.2095-4344.2012.32.020
    Abstract ( 433 )   PDF (593KB) ( 613 )   Save

    BACKGROUND: Tissue enzymatic digestion is an efficient primary culture method. This method can be used to elevate the success rate of primary cultured periodontal ligament stem cells and dental pulp stem cells.
    OBJECTIVE: To compare the success rate of primary culture, morphological properties, cell growth between periodontal ligament stem cells and dental pulp stem cells, and identify the two isolated cell lines with different cell markers.
    METHODS: Totally 20 health teeth were obtained by tooth extraction for orthodontic purposes. Among them, 16 teeth were pooled for periodontal ligament tissue, and four were pooled for dental pulp tissue. Periodontal ligament stem cells and dental pulp stem cells were isolated from these tissues by enzymatic digestion. Cell growth curve was obtained by the MTT method. Different cell markers of periodontal ligament stem cells and dental pulp stem cells were characterized by RT-PCR, immuocytochemistry staining and immunofluorescence staining.
    RESULTS AND CONCLUSION: The success rate of the primary cultured dental pulp stem cells was significantly higher than that of the periodontal ligament stem cells, and the dental pulp stem cells showed a stronger capability of proliferation than the periodontal ligament stem cells. Purified periodontal ligament stem cells and dental pulp stem cells both demonstrated normal morphological and biological characteristics, and expressed cell markers CD105, CD73, vimitin and Stro-1, but did not express CK-17 and CD45. It is indicated that tissue planting after tissue enzymatic digestion is an efficient method for primary culture of periodontal ligament stem cells and dental pulp stem cells.

    Related Articles | Metrics
    Temporal expression patterns of muscle-specific microRNAs and myogenic regulatory factors during C2C12 cell differentiation
    Song Jia, Zeng Ying, Zheng Min-ying, Zhang Cheng
    2012, 16 (32):  5999-6005.  doi: 10.3969/j.issn.2095-4344.2012.32.021
    Abstract ( 384 )   PDF (509KB) ( 546 )   Save

    BACKGROUND: The proliferation and differentiation of skeletal muscle cells are strictly regulated by multiple factors. Recently, more and more studies have indicated that microRNAs and myogenic regulatory factors as gene regulators play important roles in myogenesis.
    OBJECTIVE: To explore the temporal expression patterns of muscle-specific microRNAs (miR-1, miR-133, and miR-206) in C2C12 cells during differentiation and the regulatory function of myogenic factors.
    METHODS: C2C12 myogenic differentiation was induced in DMEM containing 2% horse serum. Inverted microscope was used to observe the alteration of their appearance, and immunofluorescence for myosin heavy chain was utilized to identify the differentiated C2C12 cells. At 0, 1, 2, 3, 4, 6 days after differentiation, the cellular totaI RNA of differentiated C2C12 cells was extracted. After reverse transcription, real-time polymerase chain reaction was used to determine the expression levels of three muscle-specific microRNAs as well as three myogenic regulatory factors (MyoD, myogenin and pax7) in differentiated C2C12 cells.
    RESULTS AND CONCLUSION: After C2C12 cells were induced for 3 days, myotubes and MHC-positive cells began to form. Later on, more and more myotubes and MHC-positive cells appear and peaked at 6 days. The expression levels of miR-1, miR-133, miR-206, MyoD and myogenin were up regulated at first during C2C12 differentiation, and then recovered close to the levels of pre-differentiation. However, pax7 was not altered. The expression levels of muscle-specific microRNAs, MyoD and myogenin during C2C12 myogenic differentiation alter so strikingly that they might have effects on C2C12 differentiation; MyoD and myogenin might be involved in the induction of muscle-specific microRNAs.

    Related Articles | Metrics
    Expression and significance of CD34 and CD133 in vasculogenic mimicry of hepatocellular carcinoma
    Zhou Teng, Xu Ge-liang, Jia Wei-dong, Liu Wen-bin, Zhang Chuan-hai, Ren Wei-hua
    2012, 16 (32):  6006-6010.  doi: 10.3969/j.issn.2095-4344.2012.32.022
    Abstract ( 380 )   PDF (445KB) ( 419 )   Save

    BACKGROUND: Formation of vasculogenic mimicry in malignant tumor is closely linked to the cancer stem cells.
    OBJECTIVE: To analyze the expression and significance of CD34 and CD133 in vasculogenic mimicry of hepatocellular carcinoma.
    METHODS: We established three-dimensional cell cultures in several cell lines, such as HCC97H cell, SMMC7721 cell and normal L02 cell. Liver cancer cells which formed vasculogenic mimicry were isolated by the laser capture microdissection, and the expressions of CD133 and CD34 were analyzed by semi-quantitative reverse transcription- polymerase chain reaction and Western blot subsequently.
    RESULTS AND CONCLUSION: HCC97H cell had the ability to form vasculogenic mimicry in three-dimensional cell cultures, while SMMC7721 and L02 cell did not had the ability. The expressions of CD133 and CD34 in HCC97H cell were significantly higher than those in SMMC7721 cell and L02 cell (P < 0.05). Highly aggressive liver cancer cell has the ability to form vasculogenic mimicry in three-dimensional cell cultures, while poorly aggressive liver cancer cell and normal liver cell do not have the ability. Liver cancer stem cells impact the formation of vasculogenic mimicry in hepatocellular carcinoma.

    Related Articles | Metrics
    Best storage time for red blood cells prior to freezing
    Wang Chi-lin, Xie Yu-bin, Qiu Ming, Kuang Kai-qi, Zhong Dai-ming
    2012, 16 (32):  6011-6013.  doi: 10.3969/j.issn.2095-4344.2012.32.023
    Abstract ( 232 )   PDF (274KB) ( 417 )   Save

    BACKGROUND: Appropriately extending the storage time of red blood cells prior to freezing and ensuring the quality of frozen red blood cells are beneficial for blood use in clinical emergency and can decrease blood costs.
    OBJECTIVE: To appropriately extend the storage time at (4±2) ℃ for rare-type red blood cells prior to freezing, to meet the needs of emergency blood transfusion in patients with rare blood types, decrease blood costs, and to reduce the work intensity.
    METHODS: A quality comparison was performed between red blood cells stored at (4±2) ℃ for 1-6 days and red blood cells stored at (4±2) ℃ for 7-12 days. According to the principle of blood preservative solution to protect red blood cells, the U.S. AABB related standards as well as the quality control results, the storage time for additive-containing red blood cells prior to freezing should be set within 14 days from the date of blood collection. Rh(D)-negative blood supplied by our center between 2001 and 2009 was statistically analyzed before and after taking this measure.
    RESULTS AND CONCLUSION: Quality test results met the national standards and two sets of quality control data showed no significant statistical difference. The storage time for red blood cells with additives prior to freezing was set within 14 days after the date of blood collection. Although the annual blood supply of Rh(D)-negative blood of our center increased year by year, the supply of frozen red blood cells was not increased and its proportion in the total blood supply decreased yearly, while the proportion of blood supply for blood stored at (4±2) ℃ increased gradually. No clinical blood quality problems were found regarding the red blood cells which were stored at (4±2) ℃ for 14 days prior to freezing. Results showed that increasing the blood supply of Rh(D)-negative blood stored at (4±2) ℃ and decreasing the blood supply of frozen red blood cells can meet the needs of emergency blood transfusion of Rh D)-negative patients in time, lower the high blood costs for preparation of frozen red blood cells, and reduce the work intensity for staffs in preparing the frozen red blood cells.

    Related Articles | Metrics
    Biological characteristics of CD133+ cells in U251 cell line sorted by magnetic-activated cell sorting
    Deng Yong-wen, Huang Meng-yi, Shu Yu-gao, Yang Zhuan-yi, Zhang Ming-yu, Fang Jia-sheng
    2012, 16 (32):  6014-6018.  doi: 10.3969/j.issn.2095-4344.2012.32.024
    Abstract ( 273 )   PDF (467KB) ( 489 )   Save

    BACKGROUND: The theory of brain tumor stem cells reports that brain tumor stem cell is the seed cell among brain tumor cells and is the key cell to occurrence, infiltration and recurrence of brain tumor.
    OBJECTIVE: To investigate the biological characteristics of CD133+ cells in U251.
    METHODS: CD133+ and CD133- subpopulation cells in the human GBM U251 cell line were sorted by magnetic-activated cell sorting. The purification of CD133+ subpopulation was performed by flow cytometry. MTT and monoclone forming rate assay were performed to investigate the capacity of self-renewal and clonogenic potential of the subpopulation cells. Immunofluorescence staining was performed to investigate the multidiferentiation of CD133+ cells. The tumorigenic potential of the two subpopulation cells in vivo was investigated by xenografting in BALB/c nude mouse brain.
    RESULTS AND CONCLUSION: Only 4.5% cells were CD133+ in the total population of U251 cell line. The CD133+ cells exhibited powerful proliferation capacity. The single CD133+ cell, rather than CD133- cells, could proliferate and form typical brain tumor spheres. Cell growth curve showed that CD133+ cells proliferated remarkably faster than CD133- cells while cultured in serum-free medium. Monoclone forming rate of CD133+ and CD133- cells was 78.5-92.4% and 0.8-2.4% respectively. Immunofluorescence staining showed that CD133+ cells could be induced to differentiate into mature neurocyte cells. Xenograft assay showed that CD133+ cells had tumorigenic potential in vivo, while CD133- had not. The U251 cell line contained a small proportion of CD133+ cells, which had the capacity for proliferation and multi- differentiation, and tumorigenic potential in vivo. The subpopulation of CD133+ cells was the brain tumor stem cell subpopulation in U251.

    Related Articles | Metrics
    Expression of neurotrophic factors in rats with intracerebral hemorrhage following transplantation of bone marrow stromal cells modified by glial cell line-derived neurotrphic factor gene
    Deng Li, Chang Neng-bin, Xiong Huai-lin, Gao Xiao-qing, Yang Chao-xian
    2012, 16 (32):  6019-6024.  doi: 10.3969/j.issn.2095-4344.2012.32.025
    Abstract ( 211 )   PDF (426KB) ( 396 )   Save

    BACKGROUND: Previous studies have demonstrated that cell transplantation combined with neurotrophic factor can promote neural function recovery after brain injury.
    OBJECTIVE: To explore the effects of transplantation of bone marrow stromal cells (BMSCs) modified by glial cell line-derived neurotrphic factor (GDNF) gene on expression of neurotrophic factors in rats with intracerebral hemorrhage.
    METHODS: Forty-eight rats were used to establish the models of intracerebral hemorrhage by injecting with collagenase and heparin into caudate nucleus through a stereotaxic apparatus. Then rats were randomly divided into BMSCs group, BMSCs/GDNF group and saline group and were stereotaxically injected with BMSCs, GDNF/BMSCs and saline respectively at the 3rd day after intracerebral hemorrhage induction.
    RESULTS AND CONCLUSION: Compared with saline group and BMSCs group, neurological function recovery was better in the GDNF/BMSCs group (P < 0.05). At 1, 2 weeks after cell transplantation, the expression of neurotrophic factors in the BMSCs group and GDNF/BMSCs group was significantly increased than in the saline group (P < 0.05). Transplantation of BMSCs modified by GDNF gene provides better neuroprotective effects than transplantation of simple BMSCs in treatment of intracerebral hemorrhage.

    Related Articles | Metrics
    Bone marrow mesenchymal stem cell transplantation for treating a rat model of ulcerative colitis
    Wang Wei-wei, Xu Yan-hua, Jiang Rong, Duan Zheng, Chen Xiao-yun
    2012, 16 (32):  6025-6031.  doi: 10.3969/j.issn.2095-4344.2012.32.026
    Abstract ( 218 )   PDF (565KB) ( 483 )   Save

    BACKGROUND: Recent studies have reported stem cell transplantation in repairing chronic enteritis-induced damaged tissue, but the therapeutic mechanism remains unclear.
    OBJECTIVE: To observe the distribution and differentiation of bone marrow mesenchymal stem cells (BMSCs) in the colon of ulcerative colitis rats, and the repair effect on rat colon mucosa.
    METHODS: 1×106 rat BMSCs at passage 3 were labeled by Hoechst 33342 fluorescence, and then implanted into the rats with ulcerative colitis via caudal vein. The specimen was collected at 3, 7 and 14 days following transplantation.
    RESULTS AND CONCLUSION: Fluorescently labeled BMSCs were visible in the colic mucosa of rats on day 3 following transplantation. On day 14, the number of BMSCs in the colon was abundant, and some cytokeratin-positive BMSCs could be seen in colon. At 14 days, interleukin-10 expression was increased, tumor necrosis factor alpha expression was reduced in the colon mucosa of rats with ulcerative colitis, and the pathological damage was obviously improved in the colon mucosa. These suggest that transplanted BMSCs could migrate to colonic ulcer site, differentiate into the epithelium, and promote the healing of injured colic mucosa in ulcerative colitis rats by regulating inflammatory factor expression.

    Related Articles | Metrics
    Yougui Wan combined with basic fibroblast growth factors induce the differentiation of rat bone marrow stromal cells into neuron-like cells
    Yang Ling, Zhang Zuo-tao, Zhang Li-hua, Lu Ying
    2012, 16 (32):  6032-6036.  doi: 10.3969/j.issn.2095-4344.2012.32.027
    Abstract ( 284 )   PDF (455KB) ( 381 )   Save

    BACKGROUND: Previous studies have demonstrated that Chinese medicine for tonifying kidney and benefiting essence can induce bone marrow stromal cells to differentiate into neuron-like cells.
    OBJECTIVE: To investigate the differentiation of bone marrow stromal cells into neuron-like cells under the induction of Yougui Wan combined with basic fibroblast growth factor.
    METHODS: Bone marrow stromal cells were isolated by attachment and density centrifugation. Passage 3 bone marrow stromal cells were induced to differentiate into neuron-like cells by Yougui Wan combined with basic fibroblast growth factor. Bone marrow stromal cells were divided into three groups: (1) basic fibroblast growth factor group was induced by basic fibroblast growth factor; (2) Yougui Wan+basic fibroblast growth factor group was induced by Yougui Wan and basic fibroblast growth factor; and (3) control group received no administration.
    RESULTS AND CONCLUSION: After 7 days of induction, some cells showed typical bipolar and multipolar neuronal morphology. Immunohistochemical staining results showed that neuron specific endolase, nestin and glial fibrillary acidic protein expressions in the Yougui Wan + basic fibroblast growth factor group were significantly greater than in the basic fibroblast growth factor group and control group (P < 0.05). These findings suggest that Yougui Wan combined with basic fibroblast growth factor can induce bone marrow stromal cells to differentiate into neuron-like cells.

    Related Articles | Metrics
    Transplantation of induced pluripotent stem cells for cardiac rhythm in mice with acute myocardial infarction
    Wei Xin-wei, Zhang Xiao-gang, Yang Liang
    2012, 16 (32):  6037-6041.  doi: 10.3969/j.issn.2095-4344.2012.32.028
    Abstract ( 247 )   PDF (502KB) ( 432 )   Save

    BACKGROUND: Induced pluripotent stem cells have been considered as a most promosing method for treatment of ischemic heart disease. However, the safety and efficiency of transplantation of induced pluripotent stem cells require further investigation.
    OBJECTIVE: To investigate the effects of induced pluripotent stem cells transplantation on cardiac rhythm of mice with acute myocardial infarion.
    METHODS: Acute myocardial infarction mouse models were established and were then randomly divided into acute myocardial infarction group, acute myocardial infarction + saline group, acute myocardial infarction + induced pluripotent stem cells group, and acute myocardial infarction + fibroblasts group. At the same time, a normal control group was designated. The change in the cardiac rhythm of the limb lead II surface electrocardiogram of every group was examined by BL-420 biological function system at 5 minutes, 1, 2, 3 weeks after transplantation of induced pluripotent stem cells. The expression of connexin 43 in each group was detected by immunohistochemical staining and semi-quantitatively analyzed using Image Proplus software.
    RESULTS AND CONCLUSION: Compared with acute myocardial infarction and acute myocardial infarction + fibroblast groups, the ratio of ventricular premature in the acute myocardial infarction + induced pluripotent stem cells group was obviously shortened and connexin 43 expression was significantly increased (P < 0.05). There was no significant difference between acute myocardial infarction group and acute myocardial infarction + fibroblast group. At 2 weeks after transplantation of induced pluripotent stem cells, the ratio of ventricular premature was significantly decreased, thereby the electrical activity of myocardial tissue was improved and the potential stability was enhanced, which leads to increase in connexin 43 expression. However, this phenomenon was not observed in mice receiving transplantation of fibroblasts.

    Related Articles | Metrics
    Mechanism of CD28-B7 co-stimulatory pathway to myasthenia gravis treated by peripheral blood mononuclear cells
    Liu Hong-yan, Guo Jing-ming, Wang Hai-yan, Ye Song, Ran Chang-li
    2012, 16 (32):  6042-6046.  doi: 10.3969/j.issn.2095-4344.2012.32.029
    Abstract ( 278 )   PDF (419KB) ( 332 )   Save

    BACKGROUND: There is evidence that CD28-B7 co-stimulatory pathway is closely related to myasthenia gravis. It remains unclear regarding the mechanism of CD28-B7 co-stimulatory pathway to myasthenia gravis treated by peripheral blood mononuclear cells.
    OBJECTIVE: To investigate the expression of CD28-B7 co-stimulatory pathway in a rat model of myasthenia gravis.
    METHODS: Forty female Lewis rats were divided into control group, model group, adjuvant group and stem cell transplantation group. Rats in the latter three groups were intraperitoneally administered serum from patients with myasthenia gravis to prepare myasthenia gravis models. Rats in the stem cell transplantation group were subcutaneously administered granulocyte colony stimulating factor 10 μg/kg daily for 5 successive days to mobilize bone marrow hematopoietic stem cells into the peripheral blood. Mononuclear cells were harvested from 10 mL carotid artery blood and then subjected to concentration adjustment to 2×109/L with enough amount of physiological saline. At 4, 3, 2 days before transplantation, 50 mg/kg cyclophosphamide was injected from the tail vein, once a day. On the day of transplantation, mononuclear cells were injected via the tail vein through the use of insulin injection needle. Rats in the model group were given no interventions. Rats in the adjuvant group received equal amounts of physiological and cyclophosphamide.
    RESULTS AND CONCLUSION: Titer of serum acetylcholine receptor Ab (AChR Ab titer), CD28, cytotoxic T cell antigen-4, B7.1 and B7.2 expression were significantly greater in the stem cell transplantation group than those in the model group (P < 0.01). AChR Ab titer was positively correlated with cytotoxic T cell antigen-4 in the model and stem cell transplantation groups (r = 0.236, P = 0.001 and r = 0.215, P =0.013). The Lennon scores were significantly lower in the stem cell transplantation group than in the model group (P < 0.01). These findings suggest that stem cell transplantation can regulate organism’s immune system by inhibiting CD28-B7 co-stimulatory pathway.

    Related Articles | Metrics
    MicroRNA affects bone marrow-derived stem cells, osteoblasts and osteoclasts in bone metabolism
    Fan Long-kun, Chen Yong, Hua Ze-quan
    2012, 16 (32):  6047-6052.  doi: 10.3969/j.issn.2095-4344.2012.32.030
    Abstract ( 409 )   PDF (505KB) ( 457 )   Save

    BACKGROUND: Recent studies have demonstrated that microRNA plays an important regulatory role in the differentiation of bone marrow mesenchymal stem cells (BMSCs).
    OBJECTIVE: To summarize the role of microRNA in the differentiation of BMSCs and fully investigate the mechanism underlying differentiation of BMSCs, which would provide significance for preventing and treating osteoporosis.
    METHODS: A computer online retrieval was performed by the first author in PubMed and Wanfang database to search papers regarding microRNA influencing bone metabolism by regulating BMSCs published between 1990 and 2008 with the key words microRNA,mesenchymal stem cells, bone metabolism” in Chinese or English. According to inclusion criteria, 30 papers were included for further analysis.
    RESULTS AND CONCLUSION: MicroRNA influences self-renewal and differentiation of BMSCs by regulating many transcription factors, growth factors and signal pathway. Specific microRNA related to BMSC differentiation was screened out using high-throughput technique. The underlying molecular mechanism would provide important significance for clarifying the mechanism underlying bone metabolism disorders induced by abnormal BMSC differentiation, such as osteoporosis. Studying the mechanism underlying microRNA effects on BMSC differentiation would provide a new thought for preventing and treating metabolic bone diseases.

    Related Articles | Metrics
    Lung stem cells, lung cancer stem cells and lung cancer
    Feng Xiao-yan, Du Zhen-zong
    2012, 16 (32):  6053-6057.  doi: 10.3969/j.issn.2095-4344.2012.32.031
    Abstract ( 352 )   PDF (520KB) ( 391 )   Save

    BACKGROUND: With the emergence of cancer stem cell theory, cancer stem cell therapy has gradually emerged in the field of cancer research field. In recent years, progress has been achieved in this field.
    OBJECTIVE: To review recent research progress in lung stem cells, lung cancer stem cells and lung cancer.
    METHODS: A computer-based online search of China Journal Full-text Database and PubMed was performed for articles and reviews in Chinese and English. The key words were respectively “lung cancer stem cell, lung stem cell, lung cancer” and “lung cancer stem cell, lung cancer, lung stem cell, cancer stem cell”. A total of 580 articles were searched.
    RESULTS AND CONCLUSION: Lung cancer stem cells possibly originate from stem cells in normal lung tissue. Lung cancer stem cells may be an important factor to induce lung cancer. With the research progress in lung cancer stem cell therapy for lung cancer, lung cancer treatment will enter a new stage.

    Related Articles | Metrics
    Research progress of cancer stem cells in urologic cancers
    Liu Yu, Gou Xin
    2012, 16 (32):  6058-6062.  doi: 10.3969/j.issn.2095-4344.2012.32.032
    Abstract ( 331 )   PDF (485KB) ( 444 )   Save

    BACKGROUND: Although the research about the cancer stem cells from urologic cancers is late, it also makes some achievements.
    OBJECTIVE: To review the research progress of urologic cancer stem cells in recent years.
    METHODS: Articles related to the research progress of urologic cancer stem cells in PubMed database from January 1997 to August 2011 were retrieved by the computer with the key words “cancer stem cell, urologic cancer”. A total of 289 articles were obtained from the database. The repetitive articles and non-compliant articles were excluded, and finally 30 articles were included for further analysis.
    RESULTS AND CONCLUSION: As the in-depth study of cancer stem cells, more and more cancer stem cells have been identified and isolated from kinds of tumors, and cancer stem cells in urologic cancers have acquired some advancement. Their biological characteristics, self-regulatory mechanisms and micro-environment are further understood by researches, and cancer stem cells targeted therapy will become a new way for curing urologic cancers in the future.

    Related Articles | Metrics
    Stem cell transplantation for treatment of liver cirrhosis
    Wang Juan, Shao Li-chun, Guo Qing, Kong Xin, Chen Zhe, Zhou Bo, Yang Xiao-feng
    2012, 16 (32):  6063-6070.  doi: 10.3969/j.issn.2095-4344.2012.32.033
    Abstract ( 442 )   PDF (636KB) ( 479 )   Save

    BACKGROUND: Stem cell has self-renewal and differentiation capacity, and can differentiate into hepatic lineage cells. Studies have shown that stem cell transplantation have achieved good effect for the treatment of liver cirrhosis.
    OBJECTIVE: To provide a new treatment for patients with liver cirrhosis according to umbilical cord blood stem cell transplantation, bone marrow stem cell transplantation, peripheral bloodstem cell transplantation for treatment of liver cirrhosis.
    METHODS: A retrieval was performed for the literature of the stem cell transplantation for the treatment of liver cirrhosis, using key words liver/hepatic cirrhosis; decompensated cirrhosis, peripheral vein; stem cell; transplantation; umbilical cord blood stem cell; bone marrow stem cell; autologous bone marrow stem cell and peripheral blood stem cell between 2002-01 and 2011-12 in China National Knowledge Infrastructure (CNKI) database.
    RESULTS AND CONCLUSION: Stem cells with self-renewing amplification and multi-differentiation potential can differentiate into a variety of functional cells under certain conditions. There were three kinds of stem cells in the treatment liver cirrhosis clinically at present, including umbilical cord blood stem cells, bone marrow stem cells, and peripheral blood stem cells. Although the clinical application of stem cell transplantation in the treatment of liver cirrhosis has just started, it has acquired good efficacy. The majority of patients receiving treatment showed improvement in clinical symptoms and liver function. The method is of simple, inexpensive, and can avoid immune rejection as well as without involving the ethical and other issues.

    Related Articles | Metrics
    Reinfusion of autologous bone marrow mesenchymal stem cells for treatment of stroke in 30 cases
    Chen Wen-ming, Zou Qing-yan, Lu Jian-jun, Hu Yun-xin, Hu Qiong-li, Li Zhi-gang, Zen Zhao-long
    2012, 16 (32):  6071-6075.  doi: 10.3969/j.issn.2095-4344.2012.32.034
    Abstract ( 369 )   PDF (413KB) ( 395 )   Save

    BACKGROUND: Autologous bone marrow mesenchymal stem cells have certain effects on repairing the neurologic impairment, but there are no well-controlled studies describing autologous bone marrow mesenchymal stem cells for treatment of stroke.
    OBJECTIVE: To observe the clinical effects of autologous bone marrow mesenchymal stem cell reinfusion for treatment of stroke.
    METHODS: Thirty stroke patients treated by autologous bone marrow mesenchymal stem cells reinfusion were included in the experimental group. Thirty stroke patients who did not receive autologous bone marrow mesenchymal stem cell reinfusion were included in the control group. The National Institutes of Health Stroke Scale (NIHSS) was used to assess the clinical efficacy. At 6 months after treatment, the neurological function recovery and the safety of autologous bone marrow mesenchymal stem cells were investigated.
    RESULTS AND CONCLUSION: The NIHSS score decreased significantly in the two groups after 6 months of treatment (P < 0.05). There was significant difference in NIHSS score between before and after treatment (P < 0.05). The NIHSS score of the control group decreased significantly than that of the experimental group (P < 0.05). Autologous bone marrow mesenchymal stem cell reinfusion for treatment of cerebrovascular disease is effective and safe. But this needs to be further confirmed by strictly randomized, double-blinded, controlled clinical studies involving a larger number of samples.

    Related Articles | Metrics
    HLA haploidentical and matched allogeneic hematopoietic stem cell transplantation in treatment of hematological malignancies
    Wan Ding-ming, Shao Yun-li, Qin Tong, Zhang Su-ping, Xie Xin-sheng, Sun Ling, Sun Hui, Bian Zhi-lei
    2012, 16 (32):  6076-6080.  doi: 10.3969/j.issn.2095-4344.2012.32.035
    Abstract ( 340 )   PDF (427KB) ( 553 )   Save

    BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is a very effective method in the treatment of hematologic malignancies. The haploidentical HSCT can expand the application of transplantation, and is also an important option for the patients who need a salvage transplantation without a HLA-matched donor.
    OBJECTIVE: To compare the therapeutic effects of HLA haploidentical and sibling HLA-matched allogeneic HSCT in the treatment of hematologic malignancies.
    METHODS: The clinical outcomes of 79 patients with hematologic malignancies who received allogeneic HSCT, including 26 patients with related HLA-mismatched donors and 53 patients with HLA-matched sibling were retrospectively analyzed. The incidence of graft versus host disease (GVHD), recurrence rate, and 2-year survival rate were compared between HLA-haploidentical and HLA-matched cohorts.
    RESULTS AND CONCLUSION: 78 patients achieved full engraftment, but a patient died of severe infection without engraftment at 28 days after transplantation. There was no significant difference in incidence of GVHD, incidence of relapse and 2-year disease-free survival (DFS) between HLA-haploidentical and HLA-matched cohorts (P > 0.05). The incidence of GVHD in HLA-haploidentical cohorts was significantly higher than in HLA-matched cohorts (P < 0.05), and 2-year overall survival was lower (P < 0.05) than the latter. The results suggested that the safety and effect of haploidentical HSCT with modified conditioning regimen were similar to HLA-matched HSCT for hematologic malignancies. Haploidentical HSCT is a safe and feasible approach in the treatment of hematologic malignancies without a HLA-matched related or unrelated donor.

    Related Articles | Metrics